Patents by Inventor Nigel R. Oakley

Nigel R. Oakley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040077954
    Abstract: A monitor includes cardiac and movement sensors 36, 34 responsive to a user's heart beat and a user's movement. The monitor includes a processor coupled to the sensors for generating heart-rate or other cardiac data and user movement or activity data. These data can be stored in a memory and used to analyse the relationship between heart rate and physical exertion.
    Type: Application
    Filed: December 9, 2002
    Publication date: April 22, 2004
    Applicant: Cambridge Neurotechnology Limited
    Inventors: Nigel R. Oakley, Gary S. Ungless
  • Patent number: 5225407
    Abstract: The invention relates to the use of a compound which acts as an antagonist of 5-HT at 5-HT.sub.3 receptors in the treatment of autism or another disorder originating in childhood in which there is mental retardation.
    Type: Grant
    Filed: September 8, 1992
    Date of Patent: July 6, 1993
    Assignee: Glaxo Group Limited
    Inventors: Nigel R. Oakley, Ian H. Coates, Peter C. North, Alexander W. Oxford
  • Patent number: 5032603
    Abstract: The use of the compound of formula (II) or a physiologically acceptable salt or hydrate thereof in the treatment, relief or prevention of the effects of anxiety ##STR1## The compound of formula (II) is described in UK Published Patent Application No. 2157691A.The preferred compound for use in this indication is (.+-.)-trans-5-fluoro-2,3,3a,9a-tetrahydro-1H-[1,4]-benzodioxino[2,3-c]-py rrole, especially in the form of its hydrochloride salt.
    Type: Grant
    Filed: May 15, 1990
    Date of Patent: July 16, 1991
    Assignee: Glaxo Group Limited
    Inventors: Clive A. Halliday, Nigel R. Oakley